MedPath
HSA Approval

ROSIDEN CAPSULE 20 mg

SIN06131P

ROSIDEN CAPSULE 20 mg

ROSIDEN CAPSULE 20 mg

May 22, 1991

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

M01AC01

piroxicam

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

SHIN POONG PHARMACEUTICAL CO LTD

Active Ingredients

PIROXICAM

20 mg

Piroxicam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ROSIDEN CAPSULE 20 mg - HSA Approval | MedPath